Navigation Links
LEO Pharma's PEP005 Meets Primary Endpoint in Phase III Trial for Pre-Cancerous Skin Condition
Date:2/1/2010

BALLERUP, Denmark, Feb. 1 /PRNewswire-USNewswire/ -- LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.  Findings from the REGION Ib study in body AK support results from the earlier REGION-I trial, a study evaluating PEP005 for the treatment of AK on the head reported in December 2009.

AK is a pre-cancerous skin condition that if left untreated, can lead to the development of skin cancer.

"PEP005 is a recent addition to LEO Pharma's robust dermatology pipeline.  We could not be happier with the preliminary findings that suggest PEP005 may be a promising new treatment option for patients with this type condition, a pre-cursor to skin cancer," said Lars Olsen, Executive Vice President for Research & Development, LEO Pharma.  

Cryotherapy, a procedure in which the surface skin lesions are frozen, is currently the most common treatment alternative for AK. It is used as the sole approach in approximately 75% of treatments for AK lesions, and in combination with topical drugs in approximately 9% of treatments. The American Academy of Dermatology reports that 40 percent of cases of squamous cell carcinoma begin as AKs.

Approximately 250 patients were enrolled in the REGION Ib study, which evaluated the use of a 0.05% concentration of PEP005 Gel applied daily as monotherapy for two consecutive days to AK lesions on non-head locations.  

PEP005 Gel demonstrated a favorable safety profile and was well tolerated; side effects were consistent with those seen in Phase II studies. There were no drug-related se
'/>"/>

SOURCE LEO Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
2. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
3. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
4. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
5. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
6. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
7. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
8. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
9. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
10. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
11. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 Patient engagement ... and, consequently, organizations are turning to an assortment ... As part of this evolving approach to ... educate, communicate and engage patients throughout their experiences ... patient empowerment. By mapping the patient journey and ...
(Date:7/11/2014)... DALLAS , July 11, 2014 ... report "Scintillator Market by Composition of Material, Application ... and others), End Product (Personal Instrument, Hand-Held Instruments, ... Forecast and Analysis to 2013 - 2020", published by MarketsandMarkets, ... a CAGR of 5.62% from 2014 to 2020, ...
(Date:7/11/2014)... July 11, 2014 On ... down 0.52%, the Dow Jones Industrial Average finished the day ... 1,964.68, down 0.41%. The losses were broad based as eight ... S&P 500 Health Care Sector Index ended the day at ... the last one month. Investor-Edge has initiated coverage on the ...
Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4
... , LONDON and ... AstraZeneca and Dako Denmark A/S announced today that they ... diagnostic tests for multiple AstraZeneca oncology projects, including biologics ... development. , (Logo:   http://www.newscom.com/cgi-bin/prnh/20100118/PH38535LOGO ) , ...
... Care Partners, Members Provide Dialysis Equipment, Supplies, Medications, and On-the-Ground ... , PORT-AU-PRINCE, Haiti , Jan. 17 ... devastated this Caribbean country, the U.S. kidney community ... as well as dialysis equipment, medications, supplies and clinical staff ...
Cached Medicine Technology:AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments 2AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments 3U.S. Kidney Dialysis Community Responds to Haiti's Emergency Plea for Life-Saving Dialysis Care 2U.S. Kidney Dialysis Community Responds to Haiti's Emergency Plea for Life-Saving Dialysis Care 3
(Date:7/12/2014)... article released by Seattle's well known plastic surgeon, Dr. Bryan ... cosmetic surgical procedures in summer months . , As ... enliven the rainy Pacific Northwest, many people are turning their ... out as much during the winter as they had planned. ... eager to look their best for their summer vacations, and ...
(Date:7/12/2014)... Wright & Schulte LLC, an experienced law firm who is ... (case #59776/2014), announces they have launched a new TV advertising ... hair dye, Just For Men, has caused some men to ... areas. In addition to detailing symptoms that are allegedly ... being run by Wright & Schulte LLC will also provide ...
(Date:7/12/2014)... 12, 2014 Floor-grade instrument ... 4.1 out of 5. This above-average score represents ... underpinning buyer negotiation power over the three years ... Son, “during the period, surging demand for healthcare ... with new product development, have placed upward pressure ...
(Date:7/12/2014)... The largest pure occupational medicine company ... announce that it will be opening its fifth Georgia ... join four Atlanta-based Nova Medical Centers’ locations. The ... Bridge Road, and will be open from 8:30 a.m. ... Nova’s treatment philosophy of rapid return-to-work and decreased treatment ...
(Date:7/11/2014)... 2014 Recently, MagicQuinceaneraDresses.com, the popular online ... collection of 2014 Quinceanera dresses . The company’s ... to look fashionable without paying a large amount of ... to 57% off. , The company’s online shop has ... amazing special occasion outfits. In addition to exquisite Quinceanera ...
Breaking Medicine News(10 mins):Health News:Best Summer Cosmetic Surgeries Revealed in Article By Seattle Plastic Surgeon 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 3Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 4Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Nova Medical Centers To Open New Facility in Augusta, Georgia 2Health News:Cheap Quinceanera Dresses Now Available At MagicQuinceaneraDresses.com 2
... A study conducted by researchers at Imperial College London refutes ... the bodys capability to fight infection by attacking T helper ... immune defences. ,Scientists have for long been puzzled ... slow, often taking a decade or more. ,According ...
... stem cells as a cure for infertility has made considerable ... grow mature sperm from adult stem cells, says Dr.Karim Nayerina, ... Nayernia, a professor of stem biology at the University ... had successfully coaxed the embryonic stem cells of mice into ...
... laborers begin from mines and end with tuberculosis in the ... in illegal stone quarries because they get no other jobs, ... risk of getting TB. ,Saharia tribals and backward ... Chhaina, Likhiganj and Sihonia villages of Madhya Pradesh's Morena district. ...
... An overwhelming majority of Europeans are in favour of a ... new data showed Tuesday. ,Some 88 percent of ... and other indoor spaces, said a study by the European ... Markos Kyprianou said the broad support for anti-tobacco policies could ...
... that obese people are significantly more likely to have persistent ... ,The study was conducted by a team of ... in Atlanta. ,As part of the study, researchers ... asthmatics and looked at 3,059 adults with asthma, who were ...
... cause high blood pressure, heart attacks and stroke. Now US ... ,Presenting the results of their study at the ... salt and Helicobacter pylori (H pylori) bacterium interact to cause ... stomach and duodenum, the H pylori bacterium accounts for up ...
Cached Medicine News:Health News:Study Refutes Theory on HIV's Effect on White Blood Cells 2Health News:Stem Cell Answer to Infertility in Five Years, Says Scientist 2Health News:Miners in Madhya Pradesh at High Risk of Developing TB 2Health News:Obese People More Prone to Severe Persistent Asthma 2
This table has a rectangular top, adjustable height, integral leg, and rail clamp.,Standard 2" (5 cm) pad included....
This table has adjustable height, square post and adjustable leg. Includes clamps, and standard 1" (2.5 cm) pad....
... The onboard rail clamps ... O.R. tables and stretchers. ... any need for lifting. ... a stable surface combined ...
The DHS Basic Set is available with either self-tapping or non-self-tapping screws. Either instrument set provides complete instrumentation in one graphic case for use with the Universal Implant Set,...
Medicine Products: